← STAAR SURGICAL CO STAA
Market Price
$26.19
Market Cap
$1.26B
P/E Ratio
N/A
Revenue (FY 2026)
0.0% YoY
$239.44M
3-Yr CAGR: -9.4%
Net Income
0.0% YoY
-$80.45M
Net Margin: -33.6%
Free Cash Flow
-$40.05M
FCF Yield: -3.18%
EPS (Diluted)
0.0% YoY
$-1.62
Basic: $-1.62
Return on Equity
Efficiency
-23.4%
ROA: -17.8%
📊 Multi-Year Historical Performance & Trends
Financial Performance History
Revenue, Net Income & Free Cash Flow
Margins Trend (%)
Gross, Operating & Net Margins
Balance Sheet Strength
Cash, Debt & Equity
Cash Flow Generation
Operating Cash Flow vs CapEx vs FCF
📈 Year-over-Year (YoY) Growth History (STAA)
All monetary values in millions ($M)
⚠️ YoY Data Quality Alert
- FY 2026: Revenue YoY (+0.0%) is identical to Gross Profit YoY (+0.0%). Verify the underlying Revenue and Gross Profit values for FY 2026 and FY 2025.
- FY 2026: Revenue YoY (+0.0%) is identical to Net Income YoY (+0.0%). Verify the underlying Revenue and Net Income values for FY 2026 and FY 2025.
| Fiscal Year | Revenue | Revenue YoY | Gross Profit | Net Income | Net Inc YoY | Diluted EPS | EPS YoY | Op. Cash Flow | Free Cash Flow | FCF YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| FY 2017 | $90.6M | — | $64.3M | $-2.1M | — | $-0.05 | — | $2.9M | $1.8M | — |
| FY 2018 | $22.9M | -74.8% | $91.5M | $5.0M | +332.3% | $0.11 | +320.0% | $12.8M | $10.5M | +482.3% |
| FY 2019 | $20.9M | -8.8% | $15.9M | $14.0M | +182.8% | $0.30 | +172.7% | $25.8M | $15.7M | +49.2% |
| FY 2020 | $150.2M | +619.9% | $112.0M | $14.0M | 0.0% | $0.30 | 0.0% | $25.8M | $17.4M | +10.8% |
| FY 2021 | $230.5M | +53.5% | $178.6M | $24.5M | +74.4% | $0.50 | +66.7% | $44.0M | $30.3M | +74.3% |
| FY 2022 | $284.4M | +23.4% | $223.4M | $38.8M | +58.2% | $0.78 | +56.0% | $35.7M | $17.6M | -41.9% |
| FY 2023 | $322.4M | +13.4% | $252.7M | $21.3M | -44.9% | $0.43 | -44.9% | $14.6M | $-3.6M | -120.4% |
| FY 2024 | $313.9M | -2.6% | $239.6M | $-20.2M | -194.7% | $-0.41 | -195.3% | $15.7M | $-7.7M | -113.4% |
| FY 2025 | $239.4M | -23.7% | $182.4M | $-80.4M | -298.1% | $-1.62 | -295.1% | $-34.2M | $-40.0M | -422.2% |
| FY 2026 | $239.4M | 0.0% | $182.4M | $-80.4M | 0.0% | $-1.62 | 0.0% | $-34.2M | — | — |
Valuation
Market Price
$26.19
Market Cap
$1.26B
Enterprise Value
N/A
P/E Ratio
N/A
P/B Ratio
3.79
FCF Yield
-3.18%
Dividend Yield
N/A
Shares Outstanding
Profitability & Margins
Gross Margin
76.19%
Operating Margin
-38.30%
Net Margin
-33.60%
Return on Equity (ROE)
-23.37%
Return on Assets (ROA)
-17.81%
Asset Turnover
0.53x
Revenue 3-Yr CAGR
-9.44%
Financial Health & Liquidity
Current Ratio
0.45
Cash Ratio
3.75
Debt / Equity
N/A
Debt / Assets
N/A
Cash & Equivalents
$153.15M
Total Debt
N/A
Book Value / Share
$6.91
Cash Flow Efficiency
Operating Cash Flow
-$34.23M
Capital Expenditures (CapEx)
$5.82M
Free Cash Flow
-$40.05M
OCF / Revenue
-14.30%
FCF / Revenue
-16.73%
FCF 3-Yr CAGR
N/A
Per Share Metrics
EPS (Diluted)
$-1.62
EPS (Basic)
$-1.62
Dividends / Share
N/A
Book Value / Share
$6.91
EPS YoY Growth
0.00%
Balance Sheet (FY 2026)
Total Assets
$451.68M
Total Liabilities
$451.68M
Stockholders' Equity
$344.18M
Current Assets
$18.45M
Current Liabilities
$40.86M